Finding serious disease early and doing something about it while there's still time
For many patients, this makes it one of the most talked-about medical weight loss options currently available
DrugDiscovery 5 (2), 147159
The FDA collected 480 adverse event reports for compounded tirzepatide products, but these reports do not distinguish between problems caused by tirzepatide itself versus problems caused by contamination, incorrect dosing, or inactive ingredients in the compounded formulation
After each use, wipe the rubber stopper with an alcohol swab before returning it to the fridge
Those who are considering weight loss medication may also be concerned about rare but serious long-term risks, which can include: Cardiovascular concerns (Increased heart attack risk in certain populations) Gallbladder disease Pancreatitis Other limitations include: Cost: Up to $1,000-1,200/month if not covered by insurance Supply shortages: Ongoing demand has outpaced availability Needle administration: Daily or weekly subcutaneous injections may deter some users For those with health conditions like heart disease, a history of pancreatitis, or certain genetic risks, these drugs may not be appropriate